AN2 Therapeutics
Price & Volume
Stats
See moreOpen | $4.25 |
Previous Close | $4.18 |
Day Range | $4.09-$4.25 |
52W Range | $1-$7.19 |
Market Cap | $171.3M |
Shares Short | 2M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$1.05 |
News
See moreYahoo Finance • 13 days ago
AN2 Therapeutics, Inc. Reports Inducement Grants Under Listing Rule 5635(c)(4)
Yahoo Finance • 29 days ago
GSK (LSE:GSK) Deepens Its Drug Pipeline Through Two Research Partnerships
Yahoo Finance • 12 months ago
AN2 Therapeutics reports Q3 results
Yahoo Finance • last year
AN2 Therapeutics’ SWOT analysis: stock’s potential amid pipeline setbacks
About
CEO | Mr. Eric E. Easom |
CFO | Ms. Lucy O. Day CPA |
Address | 1300 El Camino Real, Menlo Park, CA, United States, 94025 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 21 |